Evidence map›Paper›PMID 33281937›Full record

ReviewTherapeutic advances in gastroenterology2020

José María Remes Troche, Enrique Coss Adame, Miguel Ángel Valdovinos Díaz, Octavio Gómez Escudero, María Eugenia Icaza Chávez, José Antonio Chávez-Barrera, Flora Zárate Mondragón, José Antonio Ruíz Velarde Velasco, Guillermo Rafael Aceves Tavares, Marco Antonio Lira Pedrín and 4 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Therapeutic advances in gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06252558 (Do Symbiotics Provide Helpful Benefits in Gastrointestinal Related Issues in Weight Loss Surgery Patients?), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06252558 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Do Symbiotics Provide Helpful Benefits in Gastrointestinal Related Issues in Weight Loss Surgery Patients?

TypeinterventionalSponsorUniversity of North FloridaRan2024 to 2024Enrolled110ConditionsBariatric Surgery CandidateArmsSymbiotic, Placebo
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. A Postbiotic ContainingMicroorganisms · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Development of Calcium Alginate Hydrogels withGels (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Structural characteristics of a neutralFrontiers in nutrition · 2025
    Article
  18. Influence of CTG repeats from the human DM1 locus on murine gut microbiota.Computational and structural biotechnology journal · 2025
    Article
  19. Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1.Computational and structural biotechnology journal · 2024
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

José María Remes TrocheInstituto e Investigaciones Médico Biológicas de la Universidad Veracruzana, Veracruz, Mexico.
Enrique Coss AdameGastroenterology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Miguel Ángel Valdovinos DíazNational Institute of Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez Secc 16, Mexico City 14080, Mexico.
Octavio Gómez EscuderoÁngeles Hospital de Puebla, Puebla, Mexico.
María Eugenia Icaza ChávezHospital Star Médica, Mérida, Yucatán, Mexico.
José Antonio Chávez-BarreraPediatric Gastroenterology Department, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Flora Zárate MondragónGastroenterology Department, Instituto Nacional de Pediatría, Mexico City, Mexico.
José Antonio Ruíz Velarde VelascoGastroenterology Service, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico.
Guillermo Rafael Aceves TavaresGastroenterology Service, Hospital General del Estado Dr. Ernesto Ramos Bours, Hermosillo, Sonora, Mexico.
Marco Antonio Lira PedrínHospital Ángeles Tijuana, Tijuana, Mexico.
Eduardo Cerda ContrerasHospital Médica Sur, Mexico City, Mexico.
Ramón Isaías Carmona SánchezAmbulatory Care Unit Christus Muguerza, San Luis Potosí, S.L.P., Mexico.
Héctor Guerra LópezLaboratorios Carnot, Mexico City, Mexico.
Rodolfo Solana OrtizLaboratorios Carnot, Mexico City, Mexico.
Hospital Médica Sur · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXHospital Civil de Guadalajara · MXInstituto Nacional de Pediatria · MXMexican Social Security Institute · MXUniversidad de Tijuana · MXUniversidad Veracruzana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysbiosis, a loss of balance between resident bacterial communities and their host, is associated with multiple diseases, including inflammatory bowel diseases (nonspecific chronic ulcerative colitis and Crohn's disease), and digestive functional disorders. Probiotics, prebiotics, synbiotic organisms and, more recently, pharmabiotics, have been shown to modulate the human microbiota. In this review, we provide an overview of the key concepts relating to probiotics, prebiotics, synbiotic organisms, and pharmabiotics, with a focus on available clinical evidence regarding the specific use of a unique pharmabiotic, the strain

Indexed as

acute diarrheaantibiotic-associated diarrheaL. acidophilus LBpharmabioticsprobiotics

Identifiers

PMID33281937
PMCPMC7692339
OpenAlexW3106586717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.